Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q3
$5.23M Sell
16,700
-44,600
-73% -$13.2M 0.09% 271
2017
Q2
$16.6M Buy
61,300
+41,400
+208% +$10.9M 0.33% 29
2017
Q1
$5.44M Buy
19,900
+13,600
+216% +$3.85M 0.18% 86
2016
Q4
$1.79M Sell
6,300
-23,400
-79% -$6.94M 0.04% 629
2016
Q3
$9.3M Buy
29,700
+8,500
+40% +$2.52M 0.19% 89
2016
Q2
$5.13M Sell
21,200
-31,800
-60% -$8.38M 0.09% 295
2016
Q1
$13.8M Sell
53,000
-17,300
-25% -$4.57M 0.24% 63
2015
Q4
$21.5M Sell
70,300
-26,000
-27% -$7.47M 0.22% 70
2015
Q3
$28.1M Buy
96,300
+58,700
+156% +$19.4M 0.27% 43
2015
Q2
$15.2M Buy
37,600
+13,900
+59% +$5.58M 0.14% 143
2015
Q1
$10M Sell
23,700
-46,700
-66% -$18.4M 0.1% 231
2014
Q4
$23.9M Buy
70,400
+10,300
+17% +$3.33M 0.15% 134
2014
Q3
$19.9M Sell
60,100
-11,200
-16% -$3.69M 0.1% 236
2014
Q2
$22.5M Buy
71,300
+40,700
+133% +$12.2M 0.11% 213
2014
Q1
$9.36M Buy
30,600
+700
+2% +$222K 0.05% 484
2013
Q4
$8.36M Buy
29,900
+2,100
+8% +$543K 0.04% 541
2013
Q3
$6.69M Buy
27,800
+9,800
+54% +$2.19M 0.04% 555
2013
Q2
$3.87M Buy
+18,000
New +$3.85M 0.02% 876

Other funds holding BIIB

Spot Trading's BIIB Position: Q3 2017 in Review

Spot Trading sold out of Biogen (BIIB) in Q3 2017, closing a stake of 9,193 shares — an estimated $2.72M sold.

Spot Trading first reported a position in BIIB in Q4 2013 and held it in 12 quarters. The position peaked at $8.26M in Q1 2016. 1,014 funds tracked by Wall St. Rank hold BIIB as of Q3 2017.

  • Spot Trading reported no remaining Biogen position as of Q3 2017 after selling out during the quarter.
  • Spot Trading sold 9,193 Biogen shares in Q3 2017, an estimated $2.72M.
  • Spot Trading first reported a position in Biogen in Q4 2013 and held it in 12 quarters.
  • Spot Trading's Biogen position peaked at $8.26M in Q1 2016.
  • 1,014 funds tracked by Wall St. Rank held Biogen as of Q3 2017.

Based on Spot Trading's 13F filing for Q3 2017, filed 6 Nov 2017.